Tech Company Financing Transactions
ThermaGenix Funding Round
On 4/21/2017, ThermaGenix raised $1.5 million in Series A financing from private investors.
Transaction Overview
Company Name
Announced On
4/21/2017
Transaction Type
Venture Equity
Amount
$1,500,000
Round
Series A
Investors
Proceeds Purpose
ThermaGenix will use proceeds from the Series A-1 round to: Support commercial activities with its' lead products- ThermaStopTM, ThermaStop-RT and ThermaGoTM --PCR additives that improve Polymerase fidelity and PCR product purity. Broaden the range of assay utility with the LATE-PCR and Lights-On/Lights-Off application suite.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
16 Tech Cir. 201
Natick, MA 01760
USA
Natick, MA 01760
USA
Phone
Website
Email Address
Not Recorded
Overview
ThermaGo and ThermaStop DNA Polymerase Reagents are the simplest, fastest, easy-to-use additives you can find anywhere to measurably improve PCR performance.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Lawrence Wangh
President
Peter Coassin
Browse more venture capital transactions:
Prev: 4/21/2017: MakeSpace venture capital transaction
Next: 4/21/2017: Swingvy venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs